Radiopharmaceuticals Drafting Group
The Radiopharmaceuticals Drafting Group was set up by the Committee for Medicinal Products for Human Use (CHMP) in order to draft guidelines relating to radiopharmaceuticals and to provide occasional support to scientific advice.
Mandate, rules of procedure and work programme
More information on the Drafting Group's responsibilities and composition is available in these documents:
-
List item
Mandate, objectives and rules of procedure for the temporary working parties and drafting groups (PDF/120.72 KB)
First published: 04/08/2010
Last updated: 04/08/2010
EMA/CHMP/319651/2010 -
List item
Work plan for the Radiopharmaceuticals Drafting Group 2018 (PDF/108.49 KB)
Adopted
First published: 20/01/2017
Last updated: 25/01/2018
EMA/CHMP/519446/2017
| EMA has temporarily suspended or scaled back certain activities since 2019 based on EMA’s business continuity plan. |
Composition
The Drafting Group is composed of European experts selected from or associated with the national agencies with specific expertise in radiopharmaceuticals. Nominations for members are adopted by the CHMP.
Members
Below (in alphabetical order of surname) are the current members of the Radiopharmaceuticals Drafting Group. The members' declarations of interests are available in the European expert list.